Skip to main content

COVID 19 Updates from RheumNow

Inequities in Telemedicine During COVID-19

MedPage Today

Health equity in the telehealth age has assumed added importance since the COVID-19 pandemic began. The Federal Communications Commission estimates that about 21 million Americans don't have access to the Internet in their homes. Other sources estimate it is closer to 162 million.

Travel During COVID-19 Pandemic

The CDC has addressed the effects and the issues of domestic and international travel on its website.  Below is a sampling of key advice.

2020 Rheumatology Year in Review

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related.

RheumNow Podcast – Lights, Camera, Zoom (1.8.2021)

Dr. Jack Cush reviews the news, journal articles and favorite blogs from this past week on RheumNow.com.

Zoomatology – Present in Absentia

Zoom has become the slam dunk answer to the pandemic. With zoom you can avoid congregations, but still attend and belong.  Because of zoom you can sustain your business and continue medical care.  With zoom, learning moved from the classroom to the dining room for all.

COVID-19 Vaccination - Phase Ib Begins

The U.S. Centers for Disease Control and Prevention (CDC) has issued a timeline guidance document on when, how and who should get the commercially available COVID-19 vaccines. 

Telemedicine Less Utilized in the South and Urban Areas

MMWR has reported on a July 2020 survey study from 1,009 Health Resources and Services Administration–funded health centers showing that urban Health centers were more likely to provide virtual visits than those in rural areas.

Plaquenil Does Not Protect Lupus Patients from COVID-19 (Best of 2020)

Editor's note: This article originally appeared May 14, 2020, and is being shared again as part of RheumNow's "Best of 2020".

Best of 2020: Infusions in the Time of Coronavirus

Editor's note: This article originally appeared March 20, 2020, and is being shared again as part of our "Best of 2020" coverage. 

Best of 2020: My Experience as a COVID19 Vaccine Trial Participant

Editor's note: This blog originally appeared December 1, 2020, and is being shared again as part of our "Best of 2020" coverage. 

Best of 2020: The COVID-19 Global Rheumatology Registry

Editor's note: This article originally appeared March 17, 2020 and is being shared again as a "Best of 2020". 

As the highly virulent SARS-CoV-2 spreads over the world, uncertainty and fear for our patients with rheumatic diseases mount.  

Best of 2020: Some Good Things, During the Time of COVID-19

Editor's note: This blog originally appeared April 1, 2020 and is being shared again as a "Best of 2020" wrap up this year. 

Social

New QD Clinic—This week’s videos: Clinic Emergencies, Stopping Meds, 3 Issues After COVID Vaccination, My New Clinic COVID Routine, Raynaud's or Not https://t.co/R0zcRq6Sg1

Dr. John Cush RheumNow( View Tweet)

3 days 2 hours ago
RheumNow Podcast Now UP – Steroids, IVIG & the Vaccine. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more... https://t.co/f0wWTm2kV5

Dr. John Cush RheumNow( View Tweet)

3 days 21 hours ago
New Download Available on COVID-19 & mRNA Vaccines https://t.co/mvmn17Fl3B https://t.co/ceICzbDZi5
Dr. John Cush RheumNow( View Tweet)
4 days ago
QD Clinic - What to do After COVID Vaccination https://t.co/25RcMOdAkK https://t.co/EWnYJGNqvY
Dr. John Cush RheumNow( View Tweet)
4 days 3 hours ago
Hydroxychloroquine Shortage During COVID-19--According to a recent report in Annals of Rheumatic Disease, public enthusiasm for hydroxychloroquine (HCQ) created significant access issues for rheumatic patients in the early phases of the COVID-19 pandemic. https://t.co/h9hrAfv9xo https://t.co/IVSYCueK2h
Dr. John Cush RheumNow( View Tweet)
1 week ago
National Psoriasis Foundation Task Force updated their COVID-19 guidance statements. Including Guidance 4.6, stating PsA pts who receive a mRNA-COVID vaccine should continue their biologic or oral therapies as they manag of their psoriatic disease https://t.co/byujtDET33

Dr. John Cush RheumNow( View Tweet)

1 week 2 days ago
After your 2 doses of COVID vaccine, YES you need to continue to wear a mask, cont. hand washing & social distancing - so as to continue to protect yourself and others. While vaccinated you can still become infected and spread infection. https://t.co/TkcSNx0hF1

Dr. John Cush RheumNow( View Tweet)

1 week 2 days ago
A oatint infected with COVID-19- Yes they should get vaccinated ~90days after infection has resolved.Antibody testing is not needed before you are vaccinated. Evidence suggests that reinfection is uncommon in the 90 days after initial infection. https://t.co/TkcSNx0hF1.

Dr. John Cush RheumNow( View Tweet)

1 week 3 days ago
Preprint results of the REMAP-CAP trial in the UK shows that IL-6 inhibitors, when given within 24 hrs of ICU entry for COVID-19, lowers mortality rate by 36%. Hosp mortality in 353 TCZ was 28%, 48 sarilumab was 22% in 402 controls was 36%. https://t.co/fkjOz99t0l

Dr. John Cush RheumNow( View Tweet)

1 week 3 days ago
ACR Convergence 2020 Late Breaking Abstracts available from the ACR "Spotlight" slide give away. 10 slides on COVID, Tyk2 in PsA, FAST febuxostat study, Tofa in AS and novel drugs for SLE and PSS https://t.co/DvcDyusCUR

Dr. John Cush RheumNow( View Tweet)

1 week 3 days ago
×